RESOLUTION 201-ADOPTED AS AMENDED SUBJECT: Supporting improvements to patient data privacy
RESOLVED , that our LSMS support legislation to strengthen patient data privacy protections by making health information collected or stored on smartphones and similar consumer devices subject to the same privacy protections as standard medical records. RESOLVED, that our LSMS supports the extension of existing health care privacy protections to personal health data collected by apps and wearables, preventing this data from being sold or used commercially without the consumers consent. RESOLVED, that our LSMS direct the AMA delegation to seek and or support similar policy at the national level.
RESOLUTION 202-ADOPTED SUBJECT: Uniformity of medication placement on Medicaid formulary tiers
RESOLVED that the Louisiana Medical Society urges the Louisiana Department of Health to require that all companies administering Louisiana Medicaid plans be required to uniformly place drugs in the Medicaid formulary on a specific Tier when requiring a prior authorization. For example, drug XYZ would be on Tier 1 for all companies’ Prior Authorizations, while drug ABC might be on Tier 2 for all companies.
RESOLUTION 301-ADOPTED AS AMENDED SUBJECT: Electronic nicotine delivery systems
RESOLVED, that our LSMS supports further clinical and epidemiological research of e-cigarette, or vaping, product use–associated lung injury (EVALI) and e-cigarette use; and be it further RESOLVED, that our LSMS supports the American Academy of Pediatrics 8 and Society for Adolescent Health and Medicine 9 recommendations that healthcare providers should screen children and adolescents for e-cigarette use and counsel on potential for harm; and be it further RESOLVED , that our LSMS supports a ban on the sale of flavored e-cigarettes, including menthol and mint; and be it further RESOLVED , that our LSMS condemns marketing e-cigarettes in ways that specifically appeal to children and young adults.
Made with FlippingBook Digital Publishing Software